Correlation between serum IgM antibody and viral load with clinical symptoms in neonates infected with cytomegalovirus.
10.3760/cma.j.cn112150-20211123-01080
- VernacularTitle:巨细胞病毒感染新生儿血清IgM抗体和病毒载量与临床症状的相关性研究
- Author:
Pei Hao WU
1
;
Yu ZHOU
2
;
Kai Qi WU
1
;
Bin Bin YIN
1
;
Bo ZHU
1
Author Information
1. Department of Clinical Laboratory, Women's Hospital,School of Medicine Zhejiang University, Hangzhou 310006, China.
2. Department of Clinical Laboratory, Zhejiang Provincial People's Hospital, Hangzhou 310014, China.
- Publication Type:Journal Article
- MeSH:
Infant, Newborn;
Humans;
Female;
Cytomegalovirus/genetics*;
Immunoglobulin M;
Viral Load;
Cytomegalovirus Infections/diagnosis*;
Antibodies, Viral;
Real-Time Polymerase Chain Reaction;
Thrombocytopenia/complications*;
DNA, Viral
- From:
Chinese Journal of Preventive Medicine
2022;56(11):1642-1647
- CountryChina
- Language:Chinese
-
Abstract:
To investigate the correlation between serum cytomegalovirus (CMV) IgM antibody/viral load and infection-related clinical symptoms in neonates infected with CMV, and provide basis for clinical assessment and monitoring of neonatal CMV infection. A total of 70 neonates with CMV infection admitted to neonatology in Women's Hospital, School of Medicine Zhejiang University, from January 2014 to December 2020 were included in this study. Using real-time quantitative PCR as the diagnostic criteria, congenital cytomegalovirus-infected neonates (n=29) was diagnosed within the first 3 weeks of life, otherwise, it was postnatally acquired cytomegalovirus infection (n=41). The differences in general information and clinical indicators between IgM antibody positive and negative patients were analyzed, combined with the PCR result, the correlation between the IgM/viral load and the occurrence of symptoms were analyzed. T-test and non-parametric test were used to compare the differences of indicators between groups, logistic regression was used for multivariate analysis, and ROC curve was used to evaluate the auxiliary diagnostic value of relevant indicators. In the congenital CMV infection group and the postnatally acquired CMV infection group, viral load and the proportion of symptomatic patients in IgM positive group were significantly higher than IgM negative group (Z=-2.616, P=0.008; 80% vs. 21%, P=0.005) (Z=-2.405, P=0.016; 56% vs. 19%, P=0.025). Logistic regression analysis of the included population showed the risk factors of CMV infection-related symptoms were IgM positive (OR 4.562, 95%CI:1.461-14.246,P=0.009) and viral load (OR 1.728, 95%CI:1.068-2.798,P=0.026). Regressive analysis for single symptom with correction showed IgM antibody positive was associated with hearing dysfunction(OR 3.954, 95%CI:1.066-14.677,P=0.040),the CMV viral load was associated with thrombocytopenia (OR 2.228, 95%CI:1.124-4.413,P=0.022), and brain imaging abnormalities (OR 3.956, 95%CI:1.421-11.011, P=0.008). Receiver operating characteristic (ROC) analysis showed the area under ROC curve of CMV viral load for brain imaging abnormalities was 0.883 (P<0.001), with a sensitivity of 75.0% and specificity of 90.3%. For neonates infected with CMV, the risk of infection-related clinical symptoms and hearing dysfunction may be increased when IgM antibody was positive. Meanwhile, the higher the CMV viral load at diagnosis, the higher the risk of thrombocytopenia and abnormal brain imaging.
